An integrated system for the monitoring of therapy and drug's side effects in Lymphoproliferative disorders
暂无分享,去创建一个
Emiliano Schena | Luca Vollero | Ombretta Annibali | Valeria Tomarchio | Giuseppe Cimino | Natalia Cenfra | Giuseppe Avvisati
[1] Naveen Garg,et al. Leukemia cell proliferation and death in chronic lymphocytic leukemia patients on therapy with the BTK inhibitor ibrutinib. , 2017, JCI insight.
[2] B. Cheson,et al. Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.
[3] Stephan Stilgenbauer,et al. Front-line treatment of CLL in the era of novel agents. , 2017, Cancer treatment reviews.
[4] W. Marsden. I and J , 2012 .
[5] Ilias Sachpazidis,et al. Image and medical data communication protocols for telemedicine and teleradiology , 2008 .
[6] Sam Ruby,et al. RESTful Web Services , 2007 .
[7] C. Flowers,et al. Clinical use of PI3K inhibitors in B-cell lymphoid malignancies: today and tomorrow , 2017, Expert review of anticancer therapy.
[8] A Pierratos,et al. Nocturnal hemodialysis: dialysis for the new millennium. , 1999, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[9] R. Roine,et al. Assessing telemedicine: a systematic review of the literature. , 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[10] Loredana Zollo,et al. A modular telerehabilitation architecture for upper limb robotic therapy , 2017 .